CEPS

CEPS is not an operating business — it is a Cayman-incorporated blank check company whose entire purpose, per the MD&A, is to find and merge with an unnamed target in 'financial services, digital assets, healthcare, real estate services, technology and software.' The FY2025 financials the market is pricing off are stale shell-stage stubs: net income -$63.6K, total assets of just $139K and negative stockholders' equity of -$62.6K (liabilities/equity -3.22x). Those numbers predate the substantive event — the IPO closed February 6, 2026, raising $115.0M gross (11.5M shares at $10.00 plus 300K private-placement shares) with $115.0M ($10.00/share) placed in a trust account invested in short-dated U.S. government securities. So the real balance sheet today is a trust of ~$10.00/share, not the -$62.6K equity shown.

That reframes the trade entirely. Downside is largely trust-protected: if no Business Combination closes in the Combination Period, the company winds up and redeems public shares at the per-share trust amount (~$10.00 plus interest). But at $10.40 the market is paying a ~4% premium to that floor for a deal that does not yet exist. There is no announced target, no revenue, no operating history, and — by the filing's own admission as a smaller reporting company — not even a full risk-factor disclosure. You are buying optionality on a merger that may never happen while risking the $0.40 premium.